About the bill
- Full Title
To amend the Federal Food, Drug, and Cosmetic Act to provide for the deposit in the general fund of the Treasury of fees that are collected from manufacturers of drugs and devices under chapter VII of such Act, to terminate the authority of the Food and Drug Administration to negotiate with the manufacturers on particular uses of the fees, to establish a Center for Postmarket Drug Safety and Effectiveness, to establish additional authorities to ensure the safe and effective use of drugs, and for other purposes.
Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.
Referred to Committee
Last Action: May 10, 2007
- What is a bill?
The “H.R.” in “H.R. 4816” means this is a House of Representatives bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The bill’s title was written by its sponsor.
- Committee Assignments
The committee chair determines whether a bill will move past the committee stage.
There have been no votes related to this bill.
- Subject Areas
- Find Similar Bills
Search for similar bills.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2015). H.R. 4816 — 111th Congress: Food and Drug Administration Improvement Act of 2010. Retrieved from https://www.govtrack.us/congress/bills/111/hr4816
“H.R. 4816 — 111th Congress: Food and Drug Administration Improvement Act of 2010.” www.GovTrack.us. 2010. May 28, 2015 <https://www.govtrack.us/congress/bills/111/hr4816>
|title=H.R. 4816 (111th)
|accessdate=May 28, 2015
|author=111th Congress (2010)
|date=March 10, 2010
|quote=Food and Drug Administration Improvement Act of 2010